Role of NGF signaling in the bladder after spinal cord injury

NGF信号在脊髓损伤后膀胱中的作用

基本信息

  • 批准号:
    9095711
  • 负责人:
  • 金额:
    $ 11.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-03 至 2016-08-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): We have recently published that a NGF receptor, p75, is a potential therapeutic target for the spinal cord injured: motor function after spinal cor injury (SCI) improved after oral delivery of LM11A-31, a small molecule that was designed to target p75. Effective in vivo targeting of p75 by LM11A-31 was confirmed by observation of a block in binding of a pathological proNGF to p75, suggesting that the drug can be used in other systems where p75 exerts similar pathological effects upon interaction with proNGF or other proneurotrophins. We have published that ProNGF levels increase rapidly after injury to the CNS, being released into the cerebrospinal fluid. Unlike mature NGF that binds both TrkA and p75, proNGF binds p75 selectively, thereby activating p75's downstream apoptotic cascade. NGF has been implicated in bladder dysfunction after SCI as well as in overactive bladder and interstitial cystitis/painful bladder syndromes. Under these conditions and after SCI, a significan increase in NGF levels is observed in the urine, suggesting that NGF can be a biomarker for general bladder dysfunction and may be targeted to improve bladder function. Despite the long-standing interest, however, studies that aimed at neutralizing NGF action has led to mixed results. We believe a more detailed understanding of the roles that NGF and its receptors play in bladder biology will be necessary before we focus on NGF and related neurotrophins as therapeutic target for alleviating bladder dysfunction. We have found that proNGF and proBDNF are released into the urine shortly after SCI, while mature NGF is released days later. These proneurotrophins appear to induce apoptosis of umbrella cells that are responsible for establishing the permeability barrier, as LM11A-31 administration led to retention of umbrella cells after SCI. We thus hypothesize that p75 that is expressed in umbrella cells play a role in apoptosis of umbrella cells after SCI. In addition to umbrella cells, we found that p75 is also expressed in proliferating progenitors of the urothelium during the period of urothelial hyperplasia after SCI. LM11A-31 administration attenuated this hyperplasic response, suggesting that proneurotrophins and p75 play an additional role in regulating SCI-induced hyperplasia. We thus hypothesize that p75 plays dual roles in the regeneration of the urothelium after SCI, (1) by inducing apoptosis of the umbrella cells shortly after SCI, and (2) by regulating proliferation of the progenitor cells, thereby replenishing the lost umbrella cells. Under this hypothesis, we propose to determine whether p75 induces death of umbrella cells in the urothelium after SCI (Aim 1), which will be addressed by conditional p75 mice, in which p75 is selectively deleted in umbrella cells; to determine the role of p75 in proliferation of the urothelium after SCI (Aim 2), which will be addressed by analyzing mice after SCI in which p75 is deleted in urothelial progenitors; and to determine whether LM11A-31 improves bladder function after SCI (Aim 3), which will be addressed using novel optical mapping approaches, single-unit afferent nerve recording, permeability measurements and cystometrograms (CMG) with simultaneous urethral sphincter electromyograms (EMG). We believe the outcome of this study will change our current understanding on neurotrophin action in the bladder and energize the existing effort to target neurotrophin in improving bladder function in various urological conditions.
 描述(由申请人提供):我们最近发表了NGF受体p75是脊髓损伤的潜在治疗靶点:脊髓损伤(SCI)后的运动功能在口服递送LM 11 A-31(一种设计为靶向p75的小分子)后得到改善。通过观察到病理性proNGF与p75结合的阻断,证实了LM 11 A-31对p75的有效体内靶向作用,这表明该药物可用于p75在与proNGF或其他原神经营养因子相互作用后发挥类似病理作用的其他系统中。我们已经发表了ProNGF水平在CNS损伤后迅速增加,被释放到脑脊液中。与结合TrkA和p75的成熟NGF不同,proNGF选择性地结合p75,从而激活p75的下游凋亡级联。 神经生长因子与脊髓损伤后的膀胱功能障碍以及膀胱过度活动症和间质性膀胱炎/膀胱疼痛综合征有关。在这些条件下和SCI后,在尿液中观察到NGF水平的显著增加,表明NGF可以是一般膀胱功能障碍的生物标志物,并且可以靶向改善膀胱功能。然而,尽管人们长期以来一直对此感兴趣,但旨在中和NGF作用的研究却产生了好坏参半的结果。我们相信,在我们专注于神经生长因子和相关的神经营养因子作为治疗目标,以减轻膀胱功能障碍之前,更详细地了解神经生长因子及其受体在膀胱生物学中发挥的作用将是必要的。 我们已经发现,proNGF和proBDNF在SCI后不久释放到尿液中,而成熟的NGF在几天后释放。这些原神经营养因子似乎诱导负责建立渗透性屏障的伞细胞的凋亡,因为LM 11 A-31施用导致SCI后伞细胞的保留。因此,我们推测,在伞细胞中表达的p75在SCI后伞细胞的凋亡中发挥作用。除了伞细胞,我们发现p75也在脊髓损伤后尿路上皮增生期间尿路上皮的增殖祖细胞中表达。LM 11 A-31给药减弱了这种增生反应,表明前神经营养素和p75在调节SCI诱导的增生中发挥了额外的作用。因此,我们假设p75在脊髓损伤后尿道鞘的再生中起双重作用,(1)在脊髓损伤后不久诱导伞细胞凋亡,(2)通过调节细胞凋亡,(3)通过调节细胞凋亡。 祖细胞的增殖,从而补充丢失的伞细胞。在此假设下,我们建议确定p75是否诱导SCI后尿道鞘中伞细胞的死亡(目标1),这将通过条件性p75小鼠来解决,其中p75在伞细胞中被选择性地删除;为了确定p75在SCI后尿道增殖中的作用(目的2),这将通过分析SCI后的小鼠来解决,其中p75在尿路上皮祖细胞中缺失;并确定LM 11 A-31是否改善SCI后的膀胱功能(目标3),这将使用新的光学映射方法来解决,单单位传入神经记录、渗透性测量和膀胱测压图(CMG),同时进行尿道括约肌肌电图(EMG)。我们相信这项研究的结果将改变我们目前对神经营养因子在膀胱中作用的理解,并为现有的努力提供动力,以神经营养因子为目标,改善各种泌尿系统疾病的膀胱功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anthony John Kanai其他文献

Anthony John Kanai的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anthony John Kanai', 18)}}的其他基金

Nitric Oxide-Soluble Guanylate Cyclase Pathway as a Target for Male Bladder Outlet Obstruction and Lower Urinary Tract Symptoms in Aging
一氧化氮可溶性鸟苷酸环化酶途径作为男性膀胱出口梗阻和衰老过程中下尿路症状的靶标
  • 批准号:
    10733864
  • 财政年份:
    2023
  • 资助金额:
    $ 11.55万
  • 项目类别:
Novel Mechanistic Approaches in Prevention, Treatment and Non-Invasive Assessment of Radiation Cystitis in Mice
预防、治疗和非侵入性评估小鼠放射性膀胱炎的新机制方法
  • 批准号:
    10209635
  • 财政年份:
    2021
  • 资助金额:
    $ 11.55万
  • 项目类别:
Novel Mechanistic Approaches in Prevention, Treatment and Non-Invasive Assessment of Radiation Cystitis in Mice
预防、治疗和非侵入性评估小鼠放射性膀胱炎的新机制方法
  • 批准号:
    10627802
  • 财政年份:
    2021
  • 资助金额:
    $ 11.55万
  • 项目类别:
Novel Mechanistic Approaches in Prevention, Treatment and Non-Invasive Assessment of Radiation Cystitis in Mice
预防、治疗和非侵入性评估小鼠放射性膀胱炎的新机制方法
  • 批准号:
    10405017
  • 财政年份:
    2021
  • 资助金额:
    $ 11.55万
  • 项目类别:
Mechanisms/Treatments of Lower Urinary Tract Dysfunction After Spinal Cord Injury
脊髓损伤后下尿路功能障碍的机制/治疗
  • 批准号:
    8415613
  • 财政年份:
    2013
  • 资助金额:
    $ 11.55万
  • 项目类别:
Mechanisms/Treatments of Lower Urinary Tract Dysfunction After Spinal Cord Injury
脊髓损伤后下尿路功能障碍的机制/治疗
  • 批准号:
    9319726
  • 财政年份:
    2013
  • 资助金额:
    $ 11.55万
  • 项目类别:
Mechanisms/Treatments of Lower Urinary Tract Dysfunction After Spinal Cord Injury
脊髓损伤后下尿路功能障碍的机制/治疗
  • 批准号:
    8723172
  • 财政年份:
    2013
  • 资助金额:
    $ 11.55万
  • 项目类别:
Mechanisms/Treatments of Lower Urinary Tract Dysfunction After Spinal Cord Injury
脊髓损伤后下尿路功能障碍的机制/治疗
  • 批准号:
    8919880
  • 财政年份:
    2013
  • 资助金额:
    $ 11.55万
  • 项目类别:
Roles of Nitric Oxide and Superoxide in Cystitis
一氧化氮和超氧化物在膀胱炎中的作用
  • 批准号:
    6913876
  • 财政年份:
    2005
  • 资助金额:
    $ 11.55万
  • 项目类别:
Roles of Nitric Oxide and Superoxide in Cystitis
一氧化氮和超氧化物在膀胱炎中的作用
  • 批准号:
    9043860
  • 财政年份:
    2005
  • 资助金额:
    $ 11.55万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
  • 批准号:
    10596657
  • 财政年份:
    2021
  • 资助金额:
    $ 11.55万
  • 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
  • 批准号:
    10417219
  • 财政年份:
    2021
  • 资助金额:
    $ 11.55万
  • 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2015
  • 资助金额:
    $ 11.55万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2014
  • 资助金额:
    $ 11.55万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
  • 批准号:
    nhmrc : 1059331
  • 财政年份:
    2014
  • 资助金额:
    $ 11.55万
  • 项目类别:
    Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 11.55万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
  • 批准号:
    251802
  • 财政年份:
    2012
  • 资助金额:
    $ 11.55万
  • 项目类别:
    Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
  • 批准号:
    191299
  • 财政年份:
    2009
  • 资助金额:
    $ 11.55万
  • 项目类别:
    Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
  • 批准号:
    8075522
  • 财政年份:
    2009
  • 资助金额:
    $ 11.55万
  • 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
  • 批准号:
    7676912
  • 财政年份:
    2009
  • 资助金额:
    $ 11.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了